Literature DB >> 9665487

Comparative phenotypic studies of duct epithelial cell lines derived from normal human pancreas and pancreatic carcinoma.

N Liu1, T Furukawa, M Kobari, M S Tsao.   

Abstract

We have investigated the mRNA/protein expression of several tyrosine kinase receptors, growth factors, and p16INK4A cyclin inhibitor in cell lines derived from normal human pancreatic duct epithelium (HPDE) and compared them with those of five pancreatic ductal carcinoma cell lines. Cultured HPDE cells express low levels of epidermal growth factor receptor (EGFR), erbB2, transforming growth factor (TGF)-alpha, Met/hepatocyte growth factor receptor (HGFR), vascular endothelial growth factor (VEGF), and keratinocyte growth factor (KGF). They also expressed high levels of amphiregulin but did not express EGF and cripto. The expression levels were similar in primary normal HPDE cells and those expressing transfected E6E7 genes of human papilloma virus-16, but their immortalization appeared to enhance the expression of EGFR and Met/HGFR. In comparison, pancreatic carcinoma cell lines commonly demonstrated overexpression of EGFR, erbB2, TGF-alpha, Met/HGFR, VEGF, and KGF, but they consistently showed marked down-regulation of amphiregulin mRNA expression. In contrast to all carcinoma cell lines that showed deletions of the p16 gene, HPDE cells consistently demonstrated normal p16 genotype and its mRNA expression. This is the first report that compares the phenotypic expression of cultured pancreatic ductal carcinoma cells with epithelial cell lines derived from normal human pancreatic ducts. The findings confirm that malignant transformation of human pancreatic duct cells commonly results in a deregulation of expression of various growth factors and receptors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9665487      PMCID: PMC1852927          DOI: 10.1016/S0002-9440(10)65567-8

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  45 in total

1.  Cancer statistics, 1997.

Authors:  S L Parker; T Tong; S Bolden; P A Wingo
Journal:  CA Cancer J Clin       Date:  1997 Jan-Feb       Impact factor: 508.702

2.  Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities.

Authors:  R R Beerli; N E Hynes
Journal:  J Biol Chem       Date:  1996-03-15       Impact factor: 5.157

3.  Increased angiogenin expression in pancreatic cancer is related to cancer aggressiveness.

Authors:  S Shimoyama; F Gansauge; S Gansauge; G Negri; T Oohara; H G Beger
Journal:  Cancer Res       Date:  1996-06-15       Impact factor: 12.701

4.  Long-term culture and immortalization of epithelial cells from normal adult human pancreatic ducts transfected by the E6E7 gene of human papilloma virus 16.

Authors:  T Furukawa; W P Duguid; L Rosenberg; J Viallet; D A Galloway; M S Tsao
Journal:  Am J Pathol       Date:  1996-06       Impact factor: 4.307

5.  Frequent expression of genes for receptor tyrosine kinases and their ligands in human pancreatic cancer cells.

Authors:  T Oikawa; J Hitomi; A Kono; E Kaneko; K Yamaguchi
Journal:  Int J Pancreatol       Date:  1995-08

6.  Allelotype of pancreatic adenocarcinoma using xenograft enrichment.

Authors:  S A Hahn; A B Seymour; A T Hoque; M Schutte; L T da Costa; M S Redston; C Caldas; C L Weinstein; A Fischer; C J Yeo
Journal:  Cancer Res       Date:  1995-10-15       Impact factor: 12.701

7.  Increased expression of keratinocyte growth factor in human pancreatic cancer.

Authors:  I Siddiqi; H Funatomi; M S Kobrin; H Friess; M W Büchler; M Korc
Journal:  Biochem Biophys Res Commun       Date:  1995-10-04       Impact factor: 3.575

8.  Overexpression of HER2/neu oncogene in pancreatic cancer correlates with shortened survival.

Authors:  S Lei; H E Appert; B Nakata; D R Domenico; K Kim; J M Howard
Journal:  Int J Pancreatol       Date:  1995-02

9.  Autocrine growth loop of the epidermal growth factor receptor in normal and immortalized human bronchial epithelial cells.

Authors:  M S Tsao; H Zhu; J Viallet
Journal:  Exp Cell Res       Date:  1996-03-15       Impact factor: 3.905

10.  Immunohistochemical evaluation of HER-2/neu expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms.

Authors:  J D Day; J A Digiuseppe; C Yeo; M Lai-Goldman; S M Anderson; S N Goodman; S E Kern; R H Hruban
Journal:  Hum Pathol       Date:  1996-02       Impact factor: 3.466

View more
  67 in total

Review 1.  Chemoprevention for pancreatic cancer.

Authors:  Robert A Wolff
Journal:  Int J Gastrointest Cancer       Date:  2003

2.  A novel small-molecule inhibitor of protein kinase D blocks pancreatic cancer growth in vitro and in vivo.

Authors:  Kuzhuvelil B Harikumar; Ajaikumar B Kunnumakkara; Nobuo Ochi; Zhimin Tong; Amit Deorukhkar; Bokyung Sung; Lloyd Kelland; Stephen Jamieson; Rachel Sutherland; Tony Raynham; Mark Charles; Azadeh Bagherzadeh; Azadeh Bagherazadeh; Caroline Foxton; Alexandra Boakes; Muddasar Farooq; Dipen Maru; Parmeswaran Diagaradjane; Yoichi Matsuo; James Sinnett-Smith; Juri Gelovani; Sunil Krishnan; Bharat B Aggarwal; Enrique Rozengurt; Christopher R Ireson; Sushovan Guha
Journal:  Mol Cancer Ther       Date:  2010-05-04       Impact factor: 6.261

3.  Roles of autophagy and metabolism in pancreatic cancer cell adaptation to environmental challenges.

Authors:  Sandrina Maertin; Jason M Elperin; Ethan Lotshaw; Matthias Sendler; Steven D Speakman; Kazuki Takakura; Benjamin M Reicher; Olga A Mareninova; Paul J Grippo; Julia Mayerle; Markus M Lerch; Anna S Gukovskaya
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-07-13       Impact factor: 4.052

4.  Ethanol differentially regulates snail family of transcription factors and invasion of premalignant and malignant pancreatic ductal cells.

Authors:  Sarah T Ward; Surabhi Dangi-Garimella; Mario A Shields; Brett A Collander; Mohammed A Q Siddiqui; Seth B Krantz; Hidayatullah G Munshi
Journal:  J Cell Biochem       Date:  2011-10       Impact factor: 4.429

5.  Regulated expansion of human pancreatic beta-cells.

Authors:  Eszter Pais; Jean Park; Tamas Alexy; Vahagn Nikolian; Shundi Ge; Kit Shaw; Shantha Senadheera; Cinnamon L Hardee; Dianne Skelton; Roger Hollis; Gay M Crooks; Donald B Kohn
Journal:  Mol Ther       Date:  2010-04-13       Impact factor: 11.454

6.  Overexpression of smoothened activates the sonic hedgehog signaling pathway in pancreatic cancer-associated fibroblasts.

Authors:  Kimberly Walter; Noriyuki Omura; Seung-Mo Hong; Margaret Griffith; Audrey Vincent; Michael Borges; Michael Goggins
Journal:  Clin Cancer Res       Date:  2010-03-09       Impact factor: 12.531

7.  Genomic alterations link Rho family of GTPases to the highly invasive phenotype of pancreas cancer.

Authors:  Alec C Kimmelman; Aram F Hezel; Andrew J Aguirre; Hongwu Zheng; Ji-Hye Paik; Haoqiang Ying; Gerald C Chu; Jean X Zhang; Ergun Sahin; Giminna Yeo; Aditya Ponugoti; Roustem Nabioullin; Scott Deroo; Shenghong Yang; Xiaoxu Wang; John P McGrath; Marina Protopopova; Elena Ivanova; Jianhua Zhang; Bin Feng; Ming S Tsao; Mark Redston; Alexei Protopopov; Yonghong Xiao; P Andrew Futreal; William C Hahn; David S Klimstra; Lynda Chin; Ronald A DePinho
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-02       Impact factor: 11.205

8.  HOXB7 promotes invasion and predicts survival in pancreatic adenocarcinoma.

Authors:  Anne Nguyen Kovochich; Michael Arensman; Anna R Lay; Nagesh P Rao; Timothy Donahue; Xinmin Li; Samuel W French; David W Dawson
Journal:  Cancer       Date:  2012-08-22       Impact factor: 6.860

9.  An improved primary culture system of pancreatic duct epithelial cells from Wistar rats.

Authors:  Ke-Ling Chen; Xue-Lian Zheng; Yuan Li; Lie Yang; Zong-Guang Zhou; Xiang-Yu Zhou; Bin Zhou; Rong Wang; Jing-Jing Jiang; Li-Hui Chen; Lan Zhan
Journal:  Cytotechnology       Date:  2009-07       Impact factor: 2.058

10.  LIM only 4 is overexpressed in late stage pancreas cancer.

Authors:  Jun Yu; Kenoki Ohuchida; Kohei Nakata; Kazuhiro Mizumoto; Lin Cui; Hayato Fujita; Hiroshi Yamaguchi; Takuya Egami; Hidehisa Kitada; Masao Tanaka
Journal:  Mol Cancer       Date:  2008-12-22       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.